Authors
Partner with Simon-Kucher’s Life Sciences division
Nicholas Jacobus is a content associate for Pharmaceutical Executive and can be reached at njacobus@mjhlifesciences.com.
Sr. Principal, Global Primary Intelligence, IQVIA
Senior director at Simon-Kucher, Milan.
Founder and President, Vision2Voice Healthcare Communications
CEO and president of Young & Partners and a member of Pharm Exec’s Editorial Advisory Board. Prior to founding the firm, Young was global head of chemicals investment banking at Lehman Brothers, where he oversaw the worldwide efforts of Lehman in chemicals. Previously, he was head of the chemical groups at Salomon Brothers and Schroders. Early in his career, while with Bain & Co., Young provided corporate strategy advice to major chemical and life science companies. He also was a senior executive of J.H. Whitney & Co., one of the oldest venture capital firms, founded by the Whitney family, where he invested in pharmaceutical, biotech, and technology companies.
Young received an MBA from the Harvard Business School (Baker Scholar with High Distinction), an MS in Accounting from New York University, and a BA in Economics from Yale University. He is a certified public accountant, a chartered global management accountant, and a member of the American Institute of Certified Public Accountants and the New York State Society of Certified Public Accountants.
President and CEO of D2 Solutions, an advisory and technology firm specializing in pharmaceutical commercialization and supply chain strategies. With over 30 years of experience in the healthcare and life sciences industries, Erhardt is a recognized expert in market access, specialty distribution, and the evolving regulatory landscape. Under his leadership, D2 Solutions provides strategic guidance and digital tools that help manufacturers and providers navigate the complexities of product launches, patient access, and operational efficiency.
Derek Choy is Co-founder and Chief Product Officer of Aktana
Senior advisor to NextGen Invent Corporation
Executive Director of the Tufts Center for the Study of Drug Development (CSDD)